[Ebrotidine].
Elizalde
J I
JI
Servicio de Gastroenterología, Hospital Clínic i Provincial, Barcelona.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000494:pharmacology / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D016480:Helicobacter pylori / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D001557:Benzenesulfonates; D006635:Histamine H2 Antagonists; D013844:Thiazoles; C075156:ebrotidine
Ebrotidina.